In gastric cancer, PAK4 overexpression was found in four (8.1%) of 49 metastatic cancer specimens and none of the four patients with PAK4(+) responded to capecitabine/cisplatin chemotherapy [15]. This evidence concerns the gene PAK4 and metastatic malignant neoplasm.